ISSUER DOSSIER · CIK 0001621221

ARTELO BIOSCIENCES, INC. (ARTL)

Biotechnology and healthcare2 captured filing nodes

Business context

Core business: healthcare product development and commercialization. Products or assets: drug candidates, therapies or medical-device assets. Commercial model: research, regulatory progression and commercialization.

First captured2026-03-23

Latest filingS-1/A · 2026-03-24

Registration path0 initial filings · 2 amendments

What to watch next

Compare the next amendment against the current filing, then monitor for EFFECT or 424B. Material offering terms can change between amendments.

Latest captured filing: S-1/A · 2026-03-24 · 128 days ago.

Official filing timeline

2026-03-24S-1/A · official filing
ARTELO BIOSCIENCES, INC. (ARTL)
2026-03-23S-1/A · official filing
ARTELO BIOSCIENCES, INC. (ARTL)

Open latest official filing →